Abdera Therapeutics Inc. is a precision oncology company focused on developing next-generation effective targeted alpha radiation therapies (TATs) for patients with relapsed, refractory and metastatic cancers. For more information visit: www.abderatherapeutics.com.
Location: Canada, British Columbia, Vancouver
Employees: 1-10
Investors 1
| Date | Name | Website |
| - | adMare Bio... | admarebio.... |
Mentions in press and media 4
| Date | Title | Description |
| 24.04.2023 | Abdera Therapeutics Raises $142M in Series A And Series B Funding | Abdera Therapeutics, a Menlo Park, CA and Vancouver, Canada-based biopharmaceutical company that provides an antibody engineering ROVEr platform, raised $142M in Series A and Series B funding. Versant Ventures and Amplitude Ventures led the... |
| 20.04.2023 | Cancer-Focused Abdera Therapeutics Launches with $142M In Funding | 4 Shares Email Facebook Twitter LinkedIn Abdera Therapeutics, a newly formed cancer therapeutics upstart, emerged out of stealth on Thursday armed with $142 million in a combined Series A and Series B funding. The Series A round was led by ... |
| 20.04.2023 | Abdera Therapeutics Debuts With $142 Million in Financing to Engineer and Advance Best-in-Class Antibody-Based Radiopharmaceuticals for Cancer | - |
| - | Abdera Therapeutics | “Custom-engineered radiotherapies to attack cancer in bold new ways” |